chronic heart failure, patients with cardiac resynchronization therapy devices
Conditions
Interventions
None listed
Sponsors
National Cerebral and Cardiovascular Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients implanted with cardiac resynchronization therapy with a defibrillator or cardiac resynchronization therapy pacemaker from April 1, 2016, to March 31, 2021.
Exclusion criteria
Exclusion criteria: 1. Cases without a sufficient data for analysis 2. Patients who requested not to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite outcomes of all-cause death, heart transplantation, and heart failure hospitalization | — |
Countries
Japan
Contacts
Public ContactNobuhiko Ueda
National Cerebral and Cardiovascular Center Cardiovascular department, division of arrhythmia
Outcome results
None listed